Aclarion, Inc. SEC filings ACON

Aclarion, Inc. has 276 filings in SEC EDGAR's recent list, going back to Mar 3, 2015. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jun 4, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Aclarion, Inc. SEC filings
Form Description Filed Period
8-K Current report
Shareholder vote results
Jun 4, 2026 Jun 4, 2026
8-K Current report
Other events
Apr 22, 2026 Apr 21, 2026
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
Mar 19, 2026 Mar 19, 2026
8-K Current report
Regulation FD disclosure
Jan 13, 2026 Jan 9, 2026
8-K Current report
Material agreement
Jan 9, 2026 Jan 8, 2026
8-K Current report
Material agreement
Oct 14, 2025 Oct 13, 2025
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Sep 3, 2025 Sep 2, 2025
8-K Current report
Shareholder vote results
Jul 21, 2025 Jul 21, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jul 7, 2025 Jul 7, 2025
8-K Current report
Officer or director change
Jun 20, 2025 Jun 16, 2025
8-K Current report
Regulation FD disclosure
Apr 23, 2025 Apr 23, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Mar 28, 2025 Mar 27, 2025
8-K Current report
Other events
Mar 13, 2025 Mar 13, 2025
8-K Current report
Shareholder vote results
Mar 6, 2025 Mar 5, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure
Feb 28, 2025 Feb 28, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jan 31, 2025 Jan 30, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jan 30, 2025 Jan 29, 2025
8-K Current report
Material agreement
Jan 17, 2025 Jan 15, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jan 6, 2025 Jan 3, 2025
8-K Current report
Agreement ended
Jan 3, 2025 Jan 3, 2025
8-K Current report
Shareholder vote results
Jan 3, 2025 Dec 31, 2024
8-K Current report
Material agreement, Unregistered share sale
Nov 27, 2024 Nov 27, 2024
8-K Current report
Listing notice
Oct 11, 2024 Oct 8, 2024
8-K Current report
Material agreement, Unregistered share sale
Oct 1, 2024 Sep 30, 2024
8-K Current report
Material agreement
Sep 24, 2024 Sep 24, 2024
8-K Current report
Shareholder vote results
Sep 23, 2024 Sep 23, 2024
8-K Current report
Material agreement, Unregistered share sale
Aug 29, 2024 Aug 27, 2024
8-K Current report
Listing notice
Aug 23, 2024 Aug 22, 2024
8-K Current report
Material agreement, Unregistered share sale
Aug 16, 2024 Aug 14, 2024
8-K/A Amended current report
Material agreement
Aug 13, 2024 Aug 12, 2024
8-K Current report
Material agreement
Aug 12, 2024 Aug 12, 2024
8-K Current report
Material agreement
Jun 26, 2024 Jun 26, 2024
8-K Current report
Bylaw or fiscal year change
Jun 18, 2024 Jun 12, 2024
8-K Current report
Regulation FD disclosure
Apr 29, 2024 Apr 26, 2024
8-K Current report
Listing notice
Apr 12, 2024 Apr 8, 2024
8-K Current report
Material agreement, Other events
Feb 27, 2024 Feb 27, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 21, 2024 Feb 21, 2024
8-K Current report
Material agreement, Unregistered share sale
Jan 29, 2024 Jan 29, 2024
8-K Current report
Material agreement, Unregistered share sale
Jan 23, 2024 Jan 22, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jan 4, 2024 Jan 3, 2024
8-K Current report
Shareholder vote results
Dec 19, 2023 Dec 18, 2023
8-K Current report
Material agreement, Unregistered share sale
Nov 22, 2023 Nov 21, 2023
8-K Current report
Material agreement, Unregistered share sale
Oct 10, 2023 Oct 9, 2023
8-K Current report
Regulation FD disclosure
Sep 28, 2023 Sep 28, 2023
8-K Current report
Listing notice
Sep 7, 2023 Aug 31, 2023
8-K Current report
Material agreement, Unregistered share sale
Sep 1, 2023 Sep 1, 2023
8-K Current report
Listing notice, Auditor change
Aug 31, 2023 Aug 25, 2023
8-K Current report
Results of operations, Listing notice, Other events
Aug 25, 2023 Aug 23, 2023
8-K Current report
Material agreement, Change to shareholder rights
Aug 14, 2023 Aug 14, 2023
8-K Current report
Listing notice
Aug 10, 2023 Aug 4, 2023
8-K Current report
Auditor change
Jul 14, 2023 Jul 10, 2023
8-K Current report
Listing notice
Jul 7, 2023 Jul 5, 2023
8-K Current report
Listing notice
Jun 20, 2023 Jun 15, 2023
8-K Current report
Listing notice
May 30, 2023 May 23, 2023
8-K Current report
Results of operations, Other events
May 23, 2023 May 22, 2023
8-K Current report
Material agreement, Unregistered share sale
May 17, 2023 May 16, 2023
8-K Current report
Results of operations, Restatement
May 16, 2023 May 15, 2023
8-K/A Amended current report
Auditor change
May 15, 2023 Mar 8, 2023
8-K Current report
Listing notice
Apr 25, 2023 Apr 20, 2023
8-K Current report
Shareholder vote results, Other events
Mar 28, 2023 Mar 24, 2023
8-K Current report
Auditor change
Mar 9, 2023 Mar 8, 2023
8-K Current report
Listing notice
Mar 7, 2023 Mar 3, 2023
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Feb 17, 2023 Feb 16, 2023
8-K Current report
Listing notice
Dec 23, 2022 Dec 20, 2022
8-K Current report
Regulation FD disclosure, Other events
Oct 25, 2022 Oct 25, 2022
8-K Current report
Material agreement, Listing notice, Bylaw or fiscal year change, Other events
Apr 27, 2022 Apr 21, 2022

Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
ACON (Nasdaq), ACONW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Broomfield, CO
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1635077
Former names
Nocimed, Inc. (until Oct 26, 2021)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.